Evaluation of the efficacy and tolerability of zoledronic acid in combination with radiotherapy in patients with advanced osteolytic bone lesions
Phase of Trial: Phase IV
Latest Information Update: 25 Apr 2017
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Cancer; Cancer metastases; Pain
- Focus Therapeutic Use
- Sponsors Novartis
- 25 Apr 2012 Actual end date (December 2008) added as reported by ClinicalTrials.gov.
- 25 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Oct 2009 Planned number of patients changed from 100 to 75 as reported by ClinicalTrials.gov.